CASAMENTI, FIORELLA
 Distribuzione geografica
Continente #
NA - Nord America 11.148
EU - Europa 7.966
AS - Asia 4.220
SA - Sud America 510
AF - Africa 159
Continente sconosciuto - Info sul continente non disponibili 145
OC - Oceania 97
Totale 24.245
Nazione #
US - Stati Uniti d'America 10.986
RU - Federazione Russa 2.318
PL - Polonia 1.696
IT - Italia 1.392
SG - Singapore 1.310
CN - Cina 891
HK - Hong Kong 645
SE - Svezia 578
IE - Irlanda 559
VN - Vietnam 448
BR - Brasile 399
DE - Germania 365
KR - Corea 339
UA - Ucraina 261
FI - Finlandia 253
FR - Francia 216
GB - Regno Unito 148
IN - India 148
AU - Australia 97
CA - Canada 83
JO - Giordania 72
TR - Turchia 70
BD - Bangladesh 60
JP - Giappone 54
NG - Nigeria 42
AR - Argentina 39
NL - Olanda 39
CH - Svizzera 38
CI - Costa d'Avorio 34
IQ - Iraq 33
MX - Messico 33
ES - Italia 29
ID - Indonesia 29
PK - Pakistan 26
ZA - Sudafrica 22
BE - Belgio 20
EC - Ecuador 19
MA - Marocco 16
SC - Seychelles 13
VE - Venezuela 13
CL - Cile 10
LT - Lituania 10
MY - Malesia 9
PH - Filippine 9
PT - Portogallo 9
TW - Taiwan 9
CO - Colombia 8
CR - Costa Rica 8
PE - Perù 8
SA - Arabia Saudita 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
HN - Honduras 7
UZ - Uzbekistan 7
RO - Romania 6
BO - Bolivia 5
EU - Europa 5
KE - Kenya 5
TH - Thailandia 5
BG - Bulgaria 4
DO - Repubblica Dominicana 4
EG - Egitto 4
JM - Giamaica 4
KZ - Kazakistan 4
NP - Nepal 4
PY - Paraguay 4
BH - Bahrain 3
BJ - Benin 3
BY - Bielorussia 3
DZ - Algeria 3
GP - Guadalupe 3
GT - Guatemala 3
HU - Ungheria 3
IL - Israele 3
IR - Iran 3
KG - Kirghizistan 3
PA - Panama 3
PS - Palestinian Territory 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AM - Armenia 2
AO - Angola 2
AT - Austria 2
BB - Barbados 2
CG - Congo 2
GR - Grecia 2
HR - Croazia 2
KW - Kuwait 2
LB - Libano 2
LK - Sri Lanka 2
MT - Malta 2
MU - Mauritius 2
NI - Nicaragua 2
PR - Porto Rico 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
Totale 24.092
Città #
Santa Clara 2.113
Warsaw 1.694
Ashburn 1.166
Fairfield 932
Singapore 913
Chandler 646
Dublin 559
Hong Kong 513
Jacksonville 477
Woodbridge 414
Cambridge 353
Seattle 333
Seoul 331
San Jose 325
Houston 313
Wilmington 307
Milan 250
Beijing 248
Council Bluffs 187
Ann Arbor 185
Princeton 156
Rome 152
Dallas 150
Buffalo 149
Lauterbourg 146
The Dalles 144
Ho Chi Minh City 136
Florence 133
Hefei 125
Los Angeles 124
Boardman 114
Boston 102
Munich 101
Melbourne 91
Mumbai 85
Medford 84
Altamura 81
Lawrence 76
Helsinki 73
New York 73
Hanoi 70
Moscow 49
San Diego 49
Shanghai 45
Tokyo 44
Izmir 43
Abuja 38
Turku 38
Bern 36
Orem 35
Abidjan 34
Norwalk 33
Figino 32
Naples 31
Columbus 30
Falls Church 29
Paris 27
Turin 27
Dong Ket 26
Phoenix 26
Dearborn 25
São Paulo 25
Bremen 24
Haiphong 23
Redondo Beach 23
Hillsboro 22
Jakarta 22
Kent 21
Portsmouth 21
Bologna 20
Brooklyn 20
Brussels 20
Chicago 19
Denver 19
Frankfurt am Main 19
Amsterdam 18
San Francisco 18
Toronto 18
Da Nang 17
Chennai 16
Palermo 16
Verona 16
Atlanta 15
London 15
Brescia 14
Clifton 14
Guangzhou 14
Auburn Hills 13
Bari 13
Genoa 13
Montreal 13
Modena 12
Padua 12
Tianjin 12
Venice 12
West Jordan 12
Johannesburg 11
Manchester 11
Stockholm 11
Yubileyny 11
Totale 15.966
Nome #
Lithium Improves Hippocampal Neurogenesis,Neuropathology and Cognitive Functions in APP MutantMice 432
Oleuropein aglycone induces autophagy via the AMPK/mTOR signalling pathway: A mechanistic insight 403
Oleuropein aglycone protects against pyroglutamylated-3 amyloid-ß toxicity: biochemical, epigenetic and functional correlates 403
Oleuropein Aglycone: A Possible Drug against Degenerative Conditions. In Vivo Evidence of its Effectiveness against Alzheimer's Disease 377
The polyphenol oleuropein aglycone protects TgCRND8 mice against Aß plaque pathology 371
The Brain Cholinergic System in Neurodegenerative Diseases 351
Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation. 343
Central cholinergic antinociception induced by 5HT4 agonists: BIMU 1 and BIMU 8 325
Young human cholinergic neurons respond to physiological regulators and improve cognitive symptoms in an animal model of Alzheimer’s disease 321
Employing AD animal models for translational research: focus on dietary components 312
Neurodegeneration and the cholinergic system 276
STEREOSELECTIVE INCREASE IN CHOLINERGIC TRANSMISSION BY R-(+)- HYOSCYAMINE 273
Different Patterns of Neurodegeneration and Glia Activation in CA1 and CA3 Hippocampal Regions of TgCRND8 Mice 272
The polyphenol oleuropein aglycone modulates the PARP1-SIRT1 interplay: an in vitro and in vivo study 264
A New Kid on the Block? Carbonic Anhydrases as Possible New Targets in Alzheimer's Disease 253
Changes in cortical acetylcholine output induced by modulation of the nucleus basalis. 244
Olive oil polyphenols can be useful to prevent aging-associated neurodegeneration 239
Successful Brain Delivery of Andrographolide Loaded in Human Albumin Nanoparticles to TgCRND8 Mice, an Alzheimer’s Disease Mouse Model 232
Farmaci per le malattie neurodegenerative 225
Abnormal processing of tau in the brain of aged TgCRND8 mice 224
Cholinergic dysfunction, neuronal damage and axonal loss in TgCRND8 mice 216
Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease. 212
BRAIN-TARGETED DELIVERY OF ANDROGRAPHOLIDE USING SOLID LIPID NANOPARTICLES: IN VITRO AND IN VIVO EVALUATION 211
Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease. 210
ARE THE NEUROCHEMICAL AND BEHAVIORAL CHANGES INDUCED BY LESIONS OF THE NUCLEUS BASALIS IN THE RAT A MODEL OF ALZHEIMER'S DISEASE? 209
C-fos expression in the rat nucleus basalis upon excitotoxic lesion with quisqualic acid: a study in adult and aged animals 206
Long-term neuro-glial co-cultures as a brain aging model: hallmarks of senescence, miRNA expression profiles and comparison with in vivo models 203
Development of Blood-Brain Barrier Permeable Nanoparticles as Potential Carriers for Salvianolic Acid B to CNS 201
Amyloid-β oligomer synaptotoxicity is mimicked by oligomers of the model protein HypF-N 198
A comparison of the biochemical modifications caused by toxic and non-toxic protein oligomers in cells 197
Activation of brain cholinergic system by noncholinomimetic agents 196
Differential activation of mitogen-activated protein kinase signalling pathways in the hippocampus of CRND8 transgenic mouse, a model of Alzheimer's disease 191
Oleuropein aglycone counteracts Aβ42 toxicity in the rat brain 191
The selective cyclooxygenase-2 inhibitor rofecoxib suppresses brain inflammation and protects cholinergic neurons from excitotoxic degeneration in vivo. 189
Novel S-acyl glutathione derivatives prevent amyloid oxidative stress and cholinergic dysfunction in Alzheimer disease models. Free Radic Biol Med. 188
Oleuropein aglycone and polyphenols from olive mill waste water ameliorate cognitive deficits and neuropathology 188
Aβ plaque-associated glial reaction as a determinant of apoptotic neuronal death and cortical gliogenesis: a study in APP mutant mice 187
Acetylcholine output from the cerebral cortex, choline uptake and muscarinic receptors in morphine dependent freely-moving rats. 185
Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions. 184
Inhibition of acetylcholine-induced activation of extracellular regulated protein kinase prevents the encoding of an inhibitory avoidance response in the rat 183
Neutrophils CD11b and fibroblasts PGE2 are elevated in Alzheimer's disease 182
Employing AD animal models for effective translational research 181
Brain inflammatory reaction in an animal model of neuronal degeneration and its modulation by an anti-inflammatory drug: implication in Alzheimer's disease. 181
Acetylcholine release in freely moving rats by means of transversal dialysis coupled to an HPLC with electrochemical detection 180
Long-term ethanol consumption by rats: effect on acetylcholine release in vivo, choline acetyltransferase activity, and behavior. 180
Extracellular chaperones prevent Aβ42-induced toxicity in rat brains 178
Poly(ethyl cyanoacrylate) nanoparticles for brain delivery of andrographolide 178
Oleuropein aglycon relieves memory impairments, induces brain autophagy and reduces Aß load in the TgCRND8 mouse model of Alzheimer’s Disease 176
Albumin Nanoparticles for Brain Delivery: A Comparison of Chemical versus Thermal Methods and invivo Behavior 175
Acetylcholine release from fetal tissue homotopically grafted to the motoneuron-depleted lumbar spinal cord. An in vivo microdialysis study in the awake rat. 175
Aging of brain cholinergic neurons: pharmacological interventions. 173
Lesions of cholinergic forebrain nuclei: changes in avoidance behavior and scopolamine actions. 171
An analysis of cholecystokinin-induced increase in acetylcholine output from cerebral cortex of the rat. 171
Cholinergic dysfunction, neuronal damage and axonal loss in TGCRND8 mice. 169
The release of endogenous GABA and glutamate from the cerebral cortex in the rat. 168
Effects of 4-aminopyridine on acetylcholine output from the cerebral cortex of the rat in vivo. 167
Inhibition of GSK-3β by lithium improves amyloid pathology and learning and memory functions in a human APP transgenic mouse model 167
Beta-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: involvement of the p38MAPK pathway 166
Postnatal development of functional properties of visual cortical cells in rats with excitotoxic lesions of basal forebrain cholinergic neurons. 166
The brain cholinergic system in ageing mammals. 165
Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats. 165
Olive polyphenols: new promising agents to combat aging-associated neurodegeneration 165
Amyloid ß-peptides injection into the cholinergic nuclei: Morphological, neurochemical and behavioral effects 164
Effect of phosphatidylserine on acetylcholine output from the cerebral cortex of the rat. 164
A nutrigenomics approach for the study of anti-aging interventions: olive oil phenols and the modulation of microRNA profiles in mouse brain 164
Adult hippocampal neurogenesis and cortical gliogenesis in APP mutant mice 164
Garcinoic acid prevents β-amyloid (Aβ) deposition in the mouse brain 163
Immunogenicity and therapeutic efficacy of phage-displayed beta-amyloid epitopes 162
Rivastigmine antagonises deficits in prepulse inhibition induced by selective immunolesioning of cholinergic neurons in nucleus basalis magnocellularis 160
Comparison between flurbiprofen and its nitric oxide-releasing derivatives HCT-1026 and NCX-2216 on Abeta(1-42)-induced brain inflammation and neuronal damage in the rat 159
Nerve growth factor increases extracellular acetylcholine levels in the parietal cortex and hippocampus of aged rats and restores object recognition. 158
The brain cholinergic system as a target of cognition enhancers 157
Effect of thyrotropin releasing hormone (TRH) on acetylcholine release from different brain areas investigated by microdialysis. 152
NO-flurbiprofen attenuates excitotoxin-induced brain inflammation, and releases nitric oxide in the brain 151
Hyperphosphorylation and deposition of tau in the brain of a human APP transgenic mouse model 150
Effects of ganglioside treatment in rats with a lesion of the cholinergic forebrain nuclei. 150
Activation of the p38MAPK pathway cascade in models of neurodegenerative diseases in the rat in vivo 150
Effect of nerve growth factor and GM1 ganglioside on the recovery of cholinergic neurons after a lesion of the nucleus basalis in aging rats 149
Unilateral and bilateral nucleus basalis lesions: differences in neurochemical and behavioural recovery. 148
Olive Polyphenols: Antioxidant and Anti-Inflammatory Properties 148
Combined treatment with atorvastatin and minocycline suppresses severity of EAE 147
Prefibrillar amyloid aggregates could be generic toxins in higher organisms 147
Selective immunolesioning of cholinergic neurons in nucleus basalis magnocellularis impairs prepulse inhibition of acoustic startle. 145
Activation of MAPK pathways in the brain of TgCRND8 mice 145
Changes in presynaptic proteins, SNAP-25 and synaptophysin, in the hippocampal CA1 area in ischemic gerbils. 143
Interaction between nerve growth factor and GM1 monosialoganglioside in preventing cortical choline acetyltransferase and high affinity choline uptake decrease after lesion of the nucleus basalis. 143
Acetylcholine and amino acid neurotransmitters in epidural cups of freely moving rats: effect of acute and chronic treatment with antischizophrenic drugs. 143
The validity of animal models in the search for drugs for the aging brain. 142
Clioquinol reduces Aβ plaque load and glia reaction and improves cognitive deficits in an APP transgenic mouse model 141
Tau protein is hyperphosphorylated in the brain of 7-month-old TgCRND8 mice 141
Administration of amyloid ß-peptides into the medial septum of rats decreases acetylcholine release from hippocampus "in vivo" 140
Cellular acetylcholine content and neuronal differentiation 137
Induction of inflammatory mediators and microglial activation in mice transgenic for human P301S tau protein 137
Selective muscarinic antagonists differentially affect in vivo acetylcholine release and memory performances of young and aged rats. 136
Oleuropein aglycon relieves memory impairments, induces brain autophagy and reduces Aß load in the TgCRND8 mouse model of Alzheimer’s Disease 136
Phosphatidylserine reverses the age-dependent decrease in cortical acetylcholine release: a microdialysis study. 135
Hyperphosphorylation of tau protein in the brain of a human APP transgenic mouse model 135
Enhanced acetylcholine release in the hippocampus and cortex during acquisition of an operant behavior 135
Cholinergic function in the hippocampus of juvenile rats chronically deprived of NGF 132
Effect of BM-5, a presynaptic antagonist-postsynaptic agonist, on cortical acetylcholine release. 131
Totale 19.488
Categoria #
all - tutte 62.935
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.935


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022917 0 104 49 40 53 54 35 43 51 42 189 257
2022/20232.447 251 296 125 208 221 480 329 125 267 6 79 60
2023/2024742 47 120 154 42 52 83 29 140 7 23 23 22
2024/20256.179 208 627 397 972 1.863 758 72 357 347 146 224 208
2025/20266.944 738 916 491 303 838 301 882 348 509 411 174 1.033
2026/2027484 268 216 0 0 0 0 0 0 0 0 0 0
Totale 24.245